These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Anthrax vaccine begins a new round of tests. Marshall E Science; 2002 Jan; 295(5554):427-9. PubMed ID: 11799216 [No Abstract] [Full Text] [Related]
4. Potential biological targets of Bacillus anthracis in anti-infective approaches against the threat of bioterrorism. Bouzianas DG Expert Rev Anti Infect Ther; 2007 Aug; 5(4):665-84. PubMed ID: 17678429 [TBL] [Abstract][Full Text] [Related]
5. [Immunogenicity of the recombinant Bacillus strains with cloned gene of biosynthesis of protective antigen against Bacillus anthracis]. Mikshis NI; Kudriavtseva OM; Bolothikova MF; Shulepov DV; Novikova LV; Popov IuA; Shchukovskaia TN; Drozdov IG; Kutyrev VV Mol Gen Mikrobiol Virusol; 2007; (3):15-21. PubMed ID: 17886469 [TBL] [Abstract][Full Text] [Related]
6. [Monoclonal antibodies to B.anthracis protective antigen are capable to neutralize and to enhance the anthrax lethal toxin action in vitro]. Belova EV; Dubileĭ SA; Kravchenko TB; Kolesnikov AV; Zakharova MIu; Shemiakin IG Mol Gen Mikrobiol Virusol; 2004; (3):21-6. PubMed ID: 15354937 [TBL] [Abstract][Full Text] [Related]
7. The detection of protective antigen (PA) associated with spores of Bacillus anthracis and the effects of anti-PA antibodies on spore germination and macrophage interactions. Cote CK; Rossi CA; Kang AS; Morrow PR; Lee JS; Welkos SL Microb Pathog; 2005; 38(5-6):209-25. PubMed ID: 15925272 [TBL] [Abstract][Full Text] [Related]
8. Efficacious, nontoxigenic Bacillus anthracis spore vaccines based on strains expressing mutant variants of lethal toxin components. Mendelson I; Gat O; Aloni-Grinstein R; Altboum Z; Inbar I; Kronman C; Bar-Haim E; Cohen S; Velan B; Shafferman A Vaccine; 2005 Dec; 23(48-49):5688-97. PubMed ID: 16039760 [TBL] [Abstract][Full Text] [Related]
9. Nasal immunization with a dual antigen anthrax vaccine induced strong mucosal and systemic immune responses against toxins and bacilli. Sloat BR; Cui Z Vaccine; 2006 Sep; 24(40-41):6405-13. PubMed ID: 16828937 [TBL] [Abstract][Full Text] [Related]
11. An intranasal vaccine targeting both the Bacillus anthracis toxin and bacterium provides protection against aerosol spore challenge in rabbits. Wimer-Mackin S; Hinchcliffe M; Petrie CR; Warwood SJ; Tino WT; Williams MS; Stenz JP; Cheff A; Richardson C Vaccine; 2006 May; 24(18):3953-63. PubMed ID: 16530302 [TBL] [Abstract][Full Text] [Related]
12. Investigation of a panel of monoclonal antibodies and polyclonal sera against anthrax toxins resulted in identification of an anti-lethal factor antibody with disease-enhancing characteristics. Kulshreshtha P; Tiwari A; Priyanka ; Joon S; Sinha S; Bhatnagar R Mol Immunol; 2015 Dec; 68(2 Pt A):185-93. PubMed ID: 26364143 [TBL] [Abstract][Full Text] [Related]
18. Nasal immunization with the mixture of PA63, LF, and a PGA conjugate induced strong antibody responses against all three antigens. Sloat BR; Shaker DS; Le UM; Cui Z FEMS Immunol Med Microbiol; 2008 Mar; 52(2):169-79. PubMed ID: 18194342 [TBL] [Abstract][Full Text] [Related]